Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-25 @ 9:21 PM
Study NCT ID:
NCT00044356
Status:
COMPLETED
Last Update Posted:
2011-07-07
First Post:
2002-08-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Trial of Allovectin-7® for Metastatic Melanoma
Sponsor:
Vical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-02
Start Date Type:
None
Primary Completion Date:
2004-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-09
Completion Date Type:
ACTUAL
First Submit Date:
2002-08-26
First Submit QC Date:
None
Study First Post Date:
2002-08-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-07-05
Last Update Post Date:
2011-07-07
Last Update Post Date Type:
ESTIMATED